Landmark decision to screen for spinal muscular atrophy at birth
16 Jul 2026, 3:05 p.m.
Great Ormond Street Hospital (GOSH) is delighted at the announcement that newborn babies in England will be offered screening for spinal muscular atrophy (SMA) through the newborn blood spot, or "heel prick", test programme.
World-first gene therapy to target devastating rare immune disorder
29 Jun 2026, 11:16 a.m.
A first-of-its-kind gene therapy to treat people with CTLA-4 insufficiency is being advanced through a collaboration supported by LifeArc, and developed by scientists at UCL, with manufacturing support from NHS Blood and Transplant and GOSH.
8 years of advancing care through data and innovation
17 Jun 2026, 11:32 a.m.
We have published a new booklet showcasing how our Data Research, Innovation and Virtual Environments (DRIVE) unit is using data and technology to transform care for children and young people at Great Ormond Street Hospital (GOSH).
Through the Paediatric Excellence Initiative, the NIHR GOSH Biomedical Research Centre is building a connected, collaborative UK-wide system to accelerate paediatric research.
Researchers identify brain network linked to deadliest childhood brain cancer
15 Jun 2026, 2:25 p.m.
Researchers at GOSH and University College London have identified a human brain network associated with survival in children with diffuse midline glioma, the deadliest childhood brain cancer.
Professor Helen Cross elected to the Academy of Medical Sciences
8 Jun 2026, 5:39 p.m.
Professor Helen Cross, Paediatric Neurology Consultant at GOSH and Director of the UCL Great Ormond Street Institute of Child Health, has been elected to the prestigious Academy of Medical Sciences.
Better understanding leukaemia for children with down syndrome
7 May 2026, 2:16 p.m.
Researchers have mapped the evolution of a type of leukaemia that is exclusive to children with Down syndrome and may have identified an overarching weakness in the cancer's genetic makeup.
Gentler treatment eliminates early deaths for children with relapsed leukaemia
30 Apr 2026, 9:58 a.m.
A groundbreaking national study led by clinicians at Great Ormond Street Hospital (GOSH) has shown that children and young people with relapsed acute lymphoblastic leukaemia (ALL) can be treated safely with significantly less intensive chemotherapy.
£3M study led by patient voices targets pain in inflammatory arthritis
21 Apr 2026, 5:07 p.m.
A new £3 million research programme involving Great Ormond Street Hospital and University College London researchers aims to tackle one of the largest unmet clinical needs in inflammatory arthritis – pain reduction.
GOSH joins European health leaders to shape the future of paediatric data sharing
9 Apr 2026, noon
More than 50 clinicians, data scientists, digital health innovators and industry leaders came together in Barcelona last month to tackle one of the biggest challenges in paediatric healthcare: how to share health data safely across borders to improve care
Engineered tissue offers hope for children born with ‘missing’ food pipe
20 Mar 2026, 10 a.m.
Scientists from Great Ormond Street Hospital (GOSH) and University College London (UCL) have created the first lab‑grown oesophagus - the food pipe - shown to safely replace a full section of the organ and restore normal function, including swallowing, in
GOSH celebrates Rare Disease Day 2026 with local community
16 Mar 2026, 11:25 a.m.
GOSH specialises in rare disease research and to celebrate, we recently invited two local North London Year 4 classes to join us for the day to learn about how we care for patients with rare diseases.
Professor Francesco Muntoni wins prestigious research prize
12 Mar 2026, 9:49 a.m.
Professor Francesco Muntoni, GOSH Paediatric Neurology Consultant, has been awarded the 2026 Novo Nordisk Prize in recognition of his pioneering work transforming the outlook for children with Duchenne muscular dystrophy (DMD).
GOSH secures £1.4m in NIHR capital equipment funding to boost research capability
11 Mar 2026, 12:23 p.m.
This investment will significantly strengthen our research infrastructure and enhance our ability to deliver world‑leading paediatric research across the whole hospital.